Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06347315 · ClinicalTrials.gov registry record · NA

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

A NA study of Mild Cognitive Impairment, sponsored by Société des Produits Nestlé (SPN).

Recruiting
Registry status
NA
Development phase
380
Enrollment target
20
Study locations

NCT06347315 is a NA study of Mild Cognitive Impairment that is actively recruiting participants, run by Société des Produits Nestlé (SPN). The registered enrollment target is 380 participants, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06347315, a NA study of Mild Cognitive Impairment, is actively recruiting participants, sponsored by Société des Produits Nestlé (SPN).

RECRUITING
Registry status
NA
Development phase
380 participants
Enrollment target
20
Study locations

Study Summary

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

Conditions Studied

Mild Cognitive Impairment

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT BrainXpert

Study Locations (20)

Other

  • Hôpital Pierre Wertheimer - Bron
  • CHU de Montpellier - Hôpital Gui de Chauliac - Montpellier
  • CHU de Nantes - Hôpital Nord Laennec - Nantes
  • CHU de Toulouse - Gerontopole - Toulouse
  • Klinikum Bayreuth GmbH - Klinik Hohe Warte - Bayreuth
  • Studienzentrum für Neurologie und Psychiatrie - Böblingen
  • Neuro Centrum Science GmbH - Erbach im Odenwald
  • Universitaetsmedizin Ulm - Ulm
  • Foundation Institute G.Giglio - Cefalù
  • IRCCS Ospedale Policlinico San Martino - Genova
  • Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" - Palermo
  • AOU Policlinico Umberto I - Sapienza Università di Roma - Roma
  • Azienda Ospedaliera SantAndrea - Roma
  • Laboratory of Neuropsyichiatry, Fondazione Santa Lucia IRCCS - Roma
  • Policlinico Universitario Agostino Gemelli - Roma
  • AO Card. G. Panico - Tricase
  • Hospital Universitario del Vinalopó - Alicante
  • Fundaciò ACE - Barcelona

Florida

  • Stein Gerontological Institute Inc - Miami

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 380 participants
Start Date 2024-05-24
Est. Completion 2027-12-15
Phase NA

Sponsor

Société des Produits Nestlé (SPN)

53 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06347315

The ClinicalTrials.gov registry entry for NCT06347315 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (70% lower). The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06347315 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Other, Florida, New York.

Frequently Asked Questions

What is clinical trial NCT06347315 about?

NCT06347315 is a clinical study titled "Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)". Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

What is the current status of trial NCT06347315?

This trial is currently recruiting. It is a NA study. The enrollment target is 380 participants. The study started on 2024-05-24. Estimated completion is 2027-12-15.

What conditions does trial NCT06347315 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT06347315?

The interventions under investigation include: Placebo (OTHER), BrainXpert (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06347315?

This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06347315 being conducted?

This trial has 20 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mild Cognitive Impairment

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.